Karetzky M S
Am J Med Sci. 1978 May-Jun;275(3):319-27. doi: 10.1097/00000441-197805000-00009.
This study evaluated cardiovascular effects of epinephrine in the treatment of asthma. Heart rates, systolic and diastolic blood pressures were monitored in 64 patients treated for acute asthma. Treatment regimens included subcutaneous epinephrine in doses of 0.1 to 0.5 mg. Pretreatment heart rates ranged from 64 to 136 beats per minute and systolic and diastolic blood pressures from 80 to 190 and 50 to 108 mm Hg respectively. Epinephrine in all doses and repeated as often as three times did not raise blood pressure or heart rates, and in the highest dose or in patients with pressures in the hypertensive range exerted a hypotensive effect. Adverse cardiovascular effects of epinephrine observed in normal subjects are significantly modified in acute asthma and its use should be considered in light of these findings.
本研究评估了肾上腺素治疗哮喘时的心血管效应。对64例急性哮喘患者的心率、收缩压和舒张压进行了监测。治疗方案包括皮下注射0.1至0.5毫克剂量的肾上腺素。治疗前心率范围为每分钟64至136次,收缩压和舒张压分别为80至190毫米汞柱和50至108毫米汞柱。所有剂量的肾上腺素,且可重复给药多达三次,均未升高血压或心率,而最高剂量的肾上腺素或血压处于高血压范围的患者会出现降压作用。在急性哮喘患者中,正常受试者身上观察到的肾上腺素的不良心血管效应会显著改变,应根据这些研究结果来考虑使用肾上腺素。